iSpecimen Inc. (NASDAQ:ISPC) Short Interest Update

iSpecimen Inc. (NASDAQ:ISPC) was the recipient of a large growth in short interest in September. As of September 15th, there was short interest totaling 220,722 shares, a growth of 53.3% from the August 31st total of 143,980 shares. Currently, 10.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 2,206,668 shares, the short-interest ratio is presently 0.1 days.

iSpecimen Stock Performance

Shares of NASDAQ ISPC opened at $1.08 on Friday. The stock has a fifty day moving average price of $1.69 and a two-hundred day moving average price of $3.27. The firm has a market cap of $2.72 million, a P/E ratio of -0.02 and a beta of 1.65. iSpecimen has a 1 year low of $1.04 and a 1 year high of $50.00.

iSpecimen (NASDAQ:ISPC) last issued its quarterly earnings results on Friday, August 14th. The company reported ($0.98) earnings per share (EPS) for the quarter. iSpecimen had a negative net margin of 2,445.40% and a negative return on equity of 524.39%. The firm had revenue of $0.15 million for the quarter.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of iSpecimen in a research report on Friday, July 17th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

About iSpecimen

iSpecimen, Inc operates a digital marketplace designed to connect life sciences researchers with human biospecimens and related clinical information. Its platform helps researchers identify and request samples such as blood, tissue, and other biological materials from hospitals, laboratories, biobanks, and other healthcare or research organizations.

The company’s services support biospecimen sourcing, patient and donor matching, inventory discovery, order management, and sample logistics.